Joachim H.
- Country
- Germany
- Department
- Haematologie
Research Overview
Data & Insights
Has run more than one trial at 0 of 160 partner sites.
Specializations
Hematologic Oncology
The investigator specializes in the treatment of advanced stage Hodgkin Lymphoma, focusing on innovative therapeutic approaches for this hematologic malignancy.
- Advanced lymphoma management
- Treatment optimization strategies
- Therapeutic efficacy assessment
The research interest centers on developing treatment protocols that balance therapeutic effectiveness with reduced toxicity profiles.
Treatment Innovation
Primary focus includes evaluation of novel therapeutic combinations, particularly the BrECADD treatment protocol compared to conventional approaches in lymphoma care.
- Treatment-related morbidity assessment
- Therapeutic protocol development
- Clinical outcomes evaluation
The investigator examines progressive treatment methodologies aimed at improving patient outcomes while minimizing adverse effects.
Therapeutic Assessment
Expertise in evaluating progression-free survival and implementing PET-guided radiotherapy approaches for residual disease management.
- Response assessment protocols
- Radiotherapy integration
- Treatment efficacy monitoring
The investigator's work encompasses comprehensive evaluation of therapeutic responses and treatment optimization strategies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.